Skip to main content
Full access
Letters
Published Online: 1 July 2012

Psychiatric Comorbidity in Arousal Disorders: Chicken or Egg?

Publication: The Journal of Neuropsychiatry and Clinical Neurosciences
To the Editor: Arousal disorder (AD) is the term used to describe undesirable behaviors occurring as a result of abnormal transition between wakefulness and nonrapid eye movement (NREM) sleep. AD includes sleepwalking, sleep talking, confusional arousals, and sleep terrors. Psychological factors have been associated with certain Ads,1,2 and comorbid mood disorders have been described with sleep terrors and sleepwalking.2 Our aim was to pragmatically determine the prevalence of anxiety and depression in a population of AD patients attending a tertiary-referral sleep clinic by using a questionnaire audit. Specific consent was considered unnecessary by the local research ethics committee.
All patients with AD without another sleep disorder and diagnosed by International Classification of Sleep Disorder Version 2 criteria (ICSD-2) were sent a previously validated Short Form-12 (SF-12) questionnaire, and the Hospital Anxiety and Depression Scale (HADS). Results were compared with mean values specific to the United Kingdom. Statistical analysis was performed with SPSS (Version 14, Chicago, IL).
Questionnaires were sent to 86 AD patients; 45% (N=39) were completed and returned. The mean age was 40 years (range: 18 to 67; SD: 11); 56% of respondents were female. Only 7 respondents (18%) had nightly symptoms; however, 87% (N=34) considered their problem moderately/very severe. The prevalence of self-reported psychiatric disorders was 26% (N=10). The SF-12 physical component summary scores were not statistically different between AD patients (51.6; SD: 8.1) and U.K. normative data (50.9; SD: 9.4); the SF-12 mental component summary scores were significantly lower in respondents (46.9; SD: 10.7) than in U.K. normative data (52.1; SD: 8.7; p<0.00001).3 HADS scores were higher in AD (7.8; SD: 4.9) for anxiety as compared with general population (6.14; SD: 3.76; p=0.03), as was depression (4.3; SD: 4.3), as compared with U.K. populations (3.68; SD: 3.07; p=0.04).4
Our study is the first to evaluate ADs using HADS and SF-12 together and to demonstrate that these questionnaires together can detect symptoms of poor mental health in patients with ADs. These techniques support the findings of earlier studies that patients with ADs have a higher than expected prevalence of psychiatric symptoms.
However, the reasons for the increased prevalence of psychiatric symptoms are unclear from this brief audit. In sleepwalking, psychiatric treatment does not improve the parasomnia;5 conversely, studies have failed to show an increased incidence of ADs in patients with anxiety disorders.1 Thus, we argue that mood disturbances in ADs are neither “chicken” nor “egg.” The increased co-occurrence of psychiatric comorbidity and its role in ADs and vice-versa requires more detailed exploration than has hitherto been undertaken. We call for large, prospective, controlled trials in patients with AD that include structured and detailed personality assessments and that also evaluate treatment measures and their impact.

References

1.
Pressman MR: Factors that predispose, prime, and precipitate NREM parasomnias in adults: clinical and forensic implications. Sleep Med Rev 2007; 11:5–30, discussion 31–33
2.
Szelenberger W, Niemcewicz S, Dabrowska AJ: Sleepwalking and night terrors: psychopathological and psychophysiological correlates. Int Rev Psychiatry 2005; 17:263–270
3.
Gandek B, Ware JE, Aaronson NK, et al.: Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998; 51:1171–1178
4.
Crawford JR, Henry JD, Crombie C, et al.: Normative data for the HADS from a large non-clinical sample. Br J Clin Psychol 2001; 40:429–434
5.
Guilleminault C, Kirisoglu C, Bao G, et al.: Adult chronic sleepwalking and its treatment based on polysomnography. Brain 2005; 128:1062–1069

Information & Authors

Information

Published In

Go to The Journal of Neuropsychiatry and Clinical Neurosciences
Go to The Journal of Neuropsychiatry and Clinical Neurosciences
The Journal of Neuropsychiatry and Clinical Neurosciences
Pages: E36
PubMed: 23037675

History

Published online: 1 July 2012
Published in print: Summer 2012

Authors

Details

Kate E. Selby
Department of Sleep Medicine; Royal Infirmary of Edinburgh, Edinburgh
Ian Morrison
Department of Neurology; Institute of Neurological Sciences; Glasgow
Renata L. Riha
Department of Sleep Medicine; Royal Infirmary of Edinburgh, Edinburgh

Notes

Correspondence: Dr. Renata L. Riha; Department of Sleep Medicine, Royal Infirmary of Edinburgh; e-mail: [email protected]

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share